GSK completes acquisition of pneumococcal vaccines maker Affinivax for $3.3bn
Affinivax is engaged in developing novel class of vaccines, including the advanced next-generation 24-valent pneumococcal vaccine candidate (AFX3772),…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
17 Aug 22
Affinivax is engaged in developing novel class of vaccines, including the advanced next-generation 24-valent pneumococcal vaccine candidate (AFX3772),…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
11 Aug 22
The merger will create a clinical-stage biopharmaceutical company focused on advancing Disc Medicine’s portfolio of haematology programmes
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
09 Aug 22
The proposed acquisition will bring leading sickle cell disease expertise, portfolio and pipeline, with potential combined worldwide sales…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
08 Aug 22
The US FDA approval is based on results from the DESTINY-Breast04, in which Enhertu reduced the risk of…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
05 Aug 22
Amgen will gain access to Tavneos, Chemocentryx’s oral small molecule drug, designed to selectively inhibit the complement component…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
05 Aug 22
Through the acquisition, Gilead will obtain MiroBio’s unique I-ReSToRE drug discovery platform, along with its complete range of…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
26 Jul 22
Upon closing of the transaction, the new entity NewAmsterdam Pharma Company will be led by Michael Davidson and…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
19 Jul 22
Haleon includes a portfolio of global brands including Advil, Centrum, Sensodyne, Robitussin, and TUMS and is expected to…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
08 Jul 22
With the acquisition of Seagen, Merck is enabled to widen its cancer drugs portfolio, which is currently led…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
06 Jul 22
The British drugmaker will acquire all the outstanding equity in TeneoTwo, along with its clinical-stage cancer therapy candidate…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates